Výsledky vyhledávání - "J G Storosum"

Placebo response in antipsychotic trials of patients with acute mania: Results of an individual patient data meta-analysis

Autor: C C M, Welten, M W J, Koeter, T, Wohlfarth, J G, Storosum, W, van den Brink, C C, Gispen-de Wied, H G M, Leufkens, D A J P, Denys

Publikováno v: European neuropsychopharmacology : the journal of the European College of Neuropsychopharmacology. 25(7)

We examined the role of placebo response in acute mania trials. Specifically, whether placebo response: (1) predicts treatment effect, (2) can be predicted by patient and study characteristics, and (3) can be predicted by a parsimonious model. We per

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=pmid________::d02c808f1e4baca091a70b256d602472
https://pubmed.ncbi.nlm.nih.gov/25907248

Zobrazit plný text záznamu

Psychiatrie

Autor: J. G. Storosum, K. van der Meer

Publikováno v: Diagnose en therapie 2009 ISBN: 9789031352821

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_________::7538f33f1bc9bd20829e0d57fff7301d
https://doi.org/10.1007/978-90-313-6613-2_16

Zobrazit plný text záznamu

[Electroconvulsive therapy in therapy-resistant mania. A case study]

Autor: M E C, Neve, J, Huyser, J H, Eshuis, J G, Storosum

Publikováno v: Tijdschrift voor psychiatrie. 49(11)

A 25-year-old woman was separated for 6 weeks on account of her suicidal and chaotic behaviour occurring within the framework of a first manic episode. Her response to medication (olanzapine 20 mg, clorazepate 50 mg and lithium (serum level 0.9 mmol/

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=pmid________::2b31ccee344393830f7f0a1ae9284d46
https://pubmed.ncbi.nlm.nih.gov/17994506

Zobrazit plný text záznamu

Effectiveness of rivastigmine in Alzheimer's disease

Autor: P. Bentham, R. Gray, E. Sellwood, J. Raftery, M. Rosler, C. E Selai, M. R Trimble, M. N Rossor, R. J Harvey, J G Storosum, B J van Zwieten-Boot, A J A Elferink

Publikováno v: BMJ. 319:640-640

Editor—Two recent reports on rivastigmine in Alzheimer’s disease1,2 provide further proof that cholinesterase inhibitors produce modest improvements in cognitive testing and in clinical impression of change. The new claim is of improved functiona

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_________::0dbf13100019fe68085383ecb5cc77ec
https://doi.org/10.1136/bmj.319.7210.640a

Zobrazit plný text záznamu